Histologic features of melanoma associated with CDKN2A genotype

J Am Acad Dermatol. 2015 Mar;72(3):496-507.e7. doi: 10.1016/j.jaad.2014.11.014. Epub 2015 Jan 13.

Abstract

Background: Inherited susceptibility genes have been associated with histopathologic characteristics of tumors.

Objective: We sought to identify associations between histology of melanomas and CDKN2A genotype.

Methods: This was a case-control study design comparing 28 histopathologic tumor features among individuals with sporadic melanomas (N = 81) and cases from melanoma families with (N = 123) and without (N = 120) CDKN2A germline mutations.

Results: Compared with CDKN2A(-) cases, mutation carriers tended to have histologic features of superficial spreading melanoma subtype including higher pigmentation (Ptrend = .02) and increased pagetoid scatter (Ptrend = .07) after adjusting for age at diagnosis, sex, and American Joint Committee on Cancer thickness category. Similar associations were observed when comparing mutation carriers with a combined group of CDKN2A(-) (wild type) and sporadic melanomas. The presence of spindle cell morphology in the vertical growth phase was also an important predictor of genotype. Of the 15 cases with this phenotype, none were observed to harbor a CDKN2A mutation.

Limitations: Our study examined rare mutations and may have been underpowered to detect small, but biologically significant associations between histology and genotype.

Conclusion: Familial melanomas with CDKN2A mutations preferentially express a histologic phenotype of dense pigmentation, high pagetoid scatter, and a non-spindle cell morphology in the vertical growth phase.

Keywords: CDKN2A; classification and regression tree analysis; familial melanoma; genetic testing; histology; pagetoid scatter; pigmentation; sporadic melanoma.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Case-Control Studies
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Melanoma / genetics*
  • Melanoma / pathology*
  • Middle Aged
  • Mutation*
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology*

Substances

  • Cyclin-Dependent Kinase Inhibitor p16